Floatz logo

N-Acetyl-L-Cysteine

Osteoarthritis, Knee

Vanderbilt University Medical CenterPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

30 Active assets in the Osteoarthritis, Knee cohort.

Asset / SponsorPhaseRating
Duloxetine
Orthopaedic Arthroscopy Knee and Shoulder Clinic
Phase 4BBB
Naproxen
Pfizer
Phase 3BB
DEXAMETHASONE
Poznan University of Medical Sciences
Phase 4BB
TRIAMCINOLONE HEXACETONIDE
Kastamonu University
Phase 4BB
DEXTROSE SOLUTION
Kastamonu University
Phase 4BB

View all 50 →

Same molecule, other indications

N-Acetyl-L-Cysteine is also rated in:

idiopathic pulmonary fibrosisDormant
BBB
Indicative ·
74 / 100
View asset →
schizophreniform disorderDormant
BBB
Indicative ·
74 / 100
View asset →
traumatic brain injuryDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →